4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-22-000039
Chief Medical Officer sold 13,000 shares at an average $21.27 ($276,549)
- Chief Medical Officer acquired 13,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KREHER NERISSA Chief Medical Officer | 2022-10-25 | Option exercise | +8,040 | $2.10 | $16,884 | 28,756 | D |
| KREHER NERISSA Chief Medical Officer | 2022-10-25 | Sale | −4,942 | $20.53 | $101,462 | 23,814 | D |
| KREHER NERISSA Chief Medical Officer | 2022-10-25 | Sale | −2,998 | $21.42 | $64,215 | 20,816 | D |
| KREHER NERISSA Chief Medical Officer | 2022-10-25 | Sale | −100 | $22.13 | $2,213 | 20,716 | D |
| KREHER NERISSA Chief Medical Officer | 2022-10-26 | Option exercise | +4,960 | $2.10 | $10,416 | 25,676 | D |
| KREHER NERISSA Chief Medical Officer | 2022-10-26 | Sale | −643 | $21.21 | $13,638 | 25,033 | D |
| KREHER NERISSA Chief Medical Officer | 2022-10-26 | Sale | −4,317 | $22.01 | $95,021 | 20,716 | D |
| Derivatives | |||||||
| KREHER NERISSA Chief Medical Officer | 2022-10-25 | Option exercise · Stock Option (Right to Buy) | −8,040 | 119,682 | D | ||
| KREHER NERISSA Chief Medical Officer | 2022-10-26 | Option exercise · Stock Option (Right to Buy) | −4,960 | 114,722 | D | ||
| Open-market sales · 13,000 sh · avg $21.27 · $276,549 | |||||||
Loading xslF345X03/wf-form4_166691093179410.xml…